Krsnaa Diagnostics Share Price in Focus; Company Teams Up with AZmed to Explore AI in Radiology

Krsnaa Diagnostics has entered a strategic collaboration with AZmed, a medical imaging technology company, to explore the use of artificial intelligence in X-ray reporting, as per the exchange filing. 

The collaboration will evaluate AZmed’s AZtrauma solution for identifying and triaging fractures, joint effusions and dislocations in X-ray images. The technology is being assessed for use within Krsnaa’s existing diagnostic network. 

AI to Support High-Volume Reporting 

Krsnaa processes more than 5 million X-rays every year, giving it a large reporting operation in which to assess the technology. The company aims to understand whether AI-assisted workflows can improve efficiency and help radiologists manage growing volumes. 

Managing Director Yash Mutha said the collaboration could help improve productivity, increase reporting capacity and support future expansion while maintaining affordable diagnostic services. 

Radiologists to Retain Clinical Control 

The company said the technology is being explored as a way to support radiologists rather than replace their role in clinical decisions. 

Dr Madhuri Ghate, Vice President of Radiology at Krsnaa Diagnostics, said the partnership would allow the company to assess how AI could make reporting workflows more efficient while keeping radiologists central to clinical decision-making. 

The potential benefits will depend on the outcome of the evaluation and successful implementation. 

Read More: RailTel Corporation Share Price in Focus After Winning ₹47.4 Crore Haryana LAN Contract! 

Krsnaa Diagnostics Share Price Performance 

As of October 22, 2026, at 1:14 PM, Krsnaa Diagnostics share price was trading at ₹514.00 per share, reflecting a 0.19% decline from the previous trading session. 

Conclusion 

The AZmed collaboration gives Krsnaa Diagnostics an opportunity to test AI-assisted reporting within its large X-ray network. The company is looking to assess whether the technology can improve workflow efficiency and create additional capacity as diagnostic demand grows. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.